Literature DB >> 25247518

Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.

Linda S Geiss1, Jing Wang1, Yiling J Cheng1, Theodore J Thompson1, Lawrence Barker1, Yanfeng Li1, Ann L Albright1, Edward W Gregg1.   

Abstract

IMPORTANCE: Although the prevalence and incidence of diabetes have increased in the United States in recent decades, no studies have systematically examined long-term, national trends in the prevalence and incidence of diagnosed diabetes.
OBJECTIVE: To examine long-term trends in the prevalence and incidence of diagnosed diabetes to determine whether there have been periods of acceleration or deceleration in rates. DESIGN, SETTING, AND PARTICIPANTS: We analyzed 1980-2012 data for 664,969 adults aged 20 to 79 years from the National Health Interview Survey (NHIS) to estimate incidence and prevalence rates for the overall civilian, noninstitutionalized, US population and by demographic subgroups (age group, sex, race/ethnicity, and educational level). MAIN OUTCOMES AND MEASURES: The annual percentage change (APC) in rates of the prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined).
RESULTS: The APC for age-adjusted prevalence and incidence of diagnosed diabetes did not change significantly during the 1980s (for prevalence, 0.2% [95% CI, -0.9% to 1.4%], P = .69; for incidence, -0.1% [95% CI, -2.5% to 2.4%], P = .93), but each increased sharply during 1990-2008 (for prevalence, 4.5% [95% CI, 4.1% to 4.9%], P < .001; for incidence, 4.7% [95% CI, 3.8% to 5.6%], P < .001) before leveling off with no significant change during 2008-2012 (for prevalence, 0.6% [95% CI, -1.9% to 3.0%], P = .64; for incidence, -5.4% [95% CI, -11.3% to 0.9%], P = .09). The prevalence per 100 persons was 3.5 (95% CI, 3.2 to 3.9) in 1990, 7.9 (95% CI, 7.4 to 8.3) in 2008, and 8.3 (95% CI, 7.9 to 8.7) in 2012. The incidence per 1000 persons was 3.2 (95% CI, 2.2 to 4.1) in 1990, 8.8 (95% CI, 7.4 to 10.3) in 2008, and 7.1 (95% CI, 6.1 to 8.2) in 2012. Trends in many demographic subpopulations were similar to these overall trends. However, incidence rates among non-Hispanic black and Hispanic adults continued to increase (for interaction, P = .03 for non-Hispanic black adults and P = .01 for Hispanic adults) at rates significantly greater than for non-Hispanic white adults. In addition, the rate of increase in prevalence was higher for adults who had a high school education or less compared with those who had more than a high school education (for interaction, P = .006 for <high school and P < .001 for high school). CONCLUSIONS AND RELEVANCE: Analyses of nationally representative data from 1980 to 2012 suggest a doubling of the incidence and prevalence of diabetes during 1990-2008, and a plateauing between 2008 and 2012. However, there appear to be continued increases in the prevalence or incidence of diabetes among subgroups, including non-Hispanic black and Hispanic subpopulations and those with a high school education or less.

Entities:  

Mesh:

Year:  2014        PMID: 25247518     DOI: 10.1001/jama.2014.11494

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  244 in total

1.  Glucocorticoid use and its association with skeletal health among U.S. adults with diabetes.

Authors:  Sarah Stark Casagrande; Catherine C Cowie; Saul Malozowski
Journal:  J Diabetes Complications       Date:  2016-06-27       Impact factor: 2.852

2.  A prospective study of yogurt and other dairy consumption in relation to incidence of type 2 diabetes among black women in the USA.

Authors:  Lynn Rosenberg; Yvonne P Robles; Shanshan Li; Edward A Ruiz-Narvaez; Julie R Palmer
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

3.  Osteoclasts in bone regeneration under type 2 diabetes mellitus.

Authors:  Zhiai Hu; Chi Ma; Yongxi Liang; Shujuan Zou; Xiaohua Liu
Journal:  Acta Biomater       Date:  2018-11-30       Impact factor: 8.947

4.  Diabetes Prevalence by Leisure-, Transportation-, and Occupation-Based Physical Activity Among Racially/Ethnically Diverse U.S. Adults.

Authors:  Anna A Divney; Rosenda Murillo; Fatima Rodriguez; Chloe A Mirzayi; Emma K Tsui; Sandra E Echeverria
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

5.  Association Between Neighborhood Supermarket Presence and Glycated Hemoglobin Levels Among Patients With Type 2 Diabetes Mellitus.

Authors:  Y Tara Zhang; Mahasin S Mujahid; Barbara A Laraia; E Margaret Warton; Samuel D Blanchard; Howard H Moffet; Janelle Downing; Andrew J Karter
Journal:  Am J Epidemiol       Date:  2017-06-15       Impact factor: 4.897

6.  Serum cotinine levels and diabetes mellitus in never smokers.

Authors:  Omayma Alshaarawy; Hosam A Elbaz
Journal:  J Diabetes Complications       Date:  2015-08-24       Impact factor: 2.852

7.  Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control Among Women of Reproductive Age.

Authors:  Laura E Britton; Jon M Hussey; Jamie L Crandell; Diane C Berry; Jada L Brooks; Amy G Bryant
Journal:  J Womens Health (Larchmt)       Date:  2018-05-14       Impact factor: 2.681

8.  Role of PTEN in TNFα induced insulin resistance.

Authors:  David A Bulger; Jermaine Conley; Spencer H Conner; Gipsy Majumdar; Solomon S Solomon
Journal:  Biochem Biophys Res Commun       Date:  2015-04-24       Impact factor: 3.575

9.  TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy.

Authors:  B S Betts-Obregon; A A Mondragon; A S Mendiola; R G LeBaron; R Asmis; T Zou; F Gonzalez-Fernandez; A T Tsin
Journal:  Eye (Lond)       Date:  2016-08-26       Impact factor: 3.775

10.  Macronutrient Intake, Diagnosis Status, and Glycemic Control Among US Hispanics/Latinos With Diabetes.

Authors:  Xueyin Wang; Molly Jung; Yasmin Mossavar-Rahmani; Daniela Sotres-Alvarez; Rebeca A Espinoza Giacinto; Amber Pirzada; Samantha A Reina; Sarah S Casagrande; Tao Wang; M Larissa Avilés-Santa; Robert C Kaplan; Qibin Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-03-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.